Cargando…

A cohort study of routinely used sepsis biomarkers and 28-day mortality

Detalles Bibliográficos
Autores principales:	De La Torre-Prados, M, Garcia-De la Torre, A, Trujillano-Férnández, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642731/ http://dx.doi.org/10.1186/cc11966

Ejemplares similares

Single pro-adrenomedullin determination in septic shock and 28-day mortality
por: Garcia-de la Torre, A, et al.
Publicado: (2014)

Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012)

Pro-adrenomedullin as prognostic biomarker in the sepsis
por: De La Torre-Prados, M, et al.
Publicado: (2013)

Biomarkers mesuared within 24 hours from the onset of septic shock and 28-day mortality
por: de la Torre-Prados, MV, et al.
Publicado: (2015)

Activated protein C consumption and coagulation parameters in severe sepsis and septic shock
por: De La Torre-Prados, M, et al.
Publicado: (2014)

Lactate quartile concentration and prognosis in severe sepsis and septic shock
por: De La Torre-Prados, M, et al.
Publicado: (2014)

Prognosis value of biomarkers in severe sepsis and septic shock
por: De La Torre-Prados, MV, et al.
Publicado: (2015)

Efficiency diagnostic and advantages of procalcitonin and C-reactive protein in the early diagnosis of sepsis
por: De la Torre-Prados, M, et al.
Publicado: (2010)

Anemia profile in critical septic patients hospitalized in the ICU
por: De la Torre-Prados, M, et al.
Publicado: (2011)

Etiology of bacteremias associated with c-reactive protein, procalcitonin and lactate levels
por: de la Torre-Prados, MV, et al.
Publicado: (2015)

Lactate in burn patients: biomarker of sepsis and mortality
por: Mokline, A, et al.
Publicado: (2012)

Prognostic value of raised procalcitonin when combined with routine biomarkers of sepsis among critically ill patients
por: Louw, J, et al.
Publicado: (2008)

Safety of 28 days consumption of a pre-workout supplement
por: Joy, Jordan M, et al.
Publicado: (2014)

Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6
por: Baldirà, Jaume, et al.
Publicado: (2023)

Examination of the health and safety aspects of 28-days ingestion of a supplement containing slow-release caffeine
por: Wells, Adam J, et al.
Publicado: (2014)

Impact of the Surviving Sepsis Campaign clinical guideline of in sepsis mortality in a public health institution in Brazil
por: de Aguiar, Suellen C, et al.
Publicado: (2013)

Trends in vital signs and routine biomarkers in sepsis patients during resuscitation in the emergency department: a prospective observational pilot study
por: Quinten, VM, et al.
Publicado: (2015)

Predictors of mortality in patients with severe sepsis admitted to an ICU
por: Araújo, Fernanda Vilas Bôas, et al.
Publicado: (2013)

SIRS criteria as predictors of mortality in patients admitted with sepsis
por: Santana, Adriell Ramalho, et al.
Publicado: (2013)

Biomarkers of sepsis in burn patients
por: Oueslati, H, et al.
Publicado: (2010)

Microalbuminuria: a biomarker of sepsis
por: Basu, S, et al.
Publicado: (2009)

A high anti-inflammatory response is associated with intermediate-term mortality in patients with sepsis
por: Frencken, JF, et al.
Publicado: (2015)

Surviving sepsis campaign guidelines for severe sepsis and septic shock: implementation and outcome of a 3-year follow up
por: Ortega, A Castellanos, et al.
Publicado: (2009)

Prediction of 28-day mortality by indocyanine green disappearance rate, other markers of hepatic function and transpulmonary thermodilution parameters: a prospective study in 154 patients
por: Huber, W, et al.
Publicado: (2013)

Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
por: de Azevedo, JRA, et al.
Publicado: (2013)

Surfactant protein A: a candidate predictive biomarker of mortality in acute respiratory distress syndrome in sepsis
por: Moroz, V, et al.
Publicado: (2014)

Platelet/leukocyte ratio as a predictor of mortality in patients with sepsis
por: Menezes, Bárbara Magalhães, et al.
Publicado: (2013)

ICU mortality rates in patients with sepsis compared with patients without sepsis
por: Melville, J, et al.
Publicado: (2015)

Antiplatelet therapy does not influence outcome or host response biomarkers during sepsis: a propensity-matched analysis
por: Wiewel, MA, et al.
Publicado: (2015)

Is the widening of the QTc associated with mortality in sepsis?
por: Nogueira, AC, et al.
Publicado: (2007)

Mortality-associated factors in elderly patients with septic shock and severe sepsis
por: Salomão, CS, et al.
Publicado: (2007)

Biomarkers in sepsis: a systematic review
por: Morriello, F, et al.
Publicado: (2015)

The Mortality in Emergency Department Sepsis: 1-year mortality rates
por: Shapiro, N, et al.
Publicado: (2004)

A strange fever in two brothers
por: La Torre, F, et al.
Publicado: (2008)

ICU mortality rates in patients with sepsis before and after the Surviving Sepsis Campaign
por: Melville, J, et al.
Publicado: (2015)

A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression
por: Footer, BW, et al.
Publicado: (2011)

Mortality rate reduction associated with a severe sepsis management protocol implementation
por: de Sousa, AG, et al.
Publicado: (2007)

Identification of novel immune regulators of tumor growth using RIPPS screening in vivo
por: Brennan, Tom, et al.
Publicado: (2015)

Prognostic value of routinely assessed serum biomarkers in septic shock
por: Lafuente, E, et al.
Publicado: (2011)

Predictors of mortality in renal transplant recipients with severe sepsis and septic shock
por: de Carvalho, Mônica Andrade, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ldk25t7vqbao7u3t08du686vr3